Conjunctival flap surgery for calcified scleromalacia after cosmetic conjunctivectomy.
Abstract
[PURPOSE] To investigate the long-term clinical course of scleromalacia with calcified plaque as a complication of cosmetic conjunctivectomy with topical mitomycin C (MMC) application and to introduce a surgical method for this complication using calcified plaque removal and/or conjunctival flap surgery.
[METHODS] Eleven patients (15 eyes, 17 lesions) were included in this retrospective study. The calcified plaque was removed with forceps and pterygium knife, and the thinned scleral lesion was covered with a conjunctival flap from an intact superior or inferior conjunctiva.
[RESULTS] There were no cases of scleral thinning or calcified plaque recurrence in patients who underwent conjunctival flap surgery. The mean interval between previous cosmetic conjunctivectomy with postsurgical topical MMC and the first surgical treatment for complications was 20.0 ± 6.4 months. The mean postoperative follow-up duration after last conjunctival flap surgery or calcified plaque removal was 11.6 ± 4.0 months.
[CONCLUSIONS] Scleral calcification and thinning progress as time passes after cosmetic conjunctivectomy with postsurgical topical MMC. Calcified plaque removal with conjunctival flap surgery can be an effective surgical management for this complication, returning blood supply to a thinned sclera.
[METHODS] Eleven patients (15 eyes, 17 lesions) were included in this retrospective study. The calcified plaque was removed with forceps and pterygium knife, and the thinned scleral lesion was covered with a conjunctival flap from an intact superior or inferior conjunctiva.
[RESULTS] There were no cases of scleral thinning or calcified plaque recurrence in patients who underwent conjunctival flap surgery. The mean interval between previous cosmetic conjunctivectomy with postsurgical topical MMC and the first surgical treatment for complications was 20.0 ± 6.4 months. The mean postoperative follow-up duration after last conjunctival flap surgery or calcified plaque removal was 11.6 ± 4.0 months.
[CONCLUSIONS] Scleral calcification and thinning progress as time passes after cosmetic conjunctivectomy with postsurgical topical MMC. Calcified plaque removal with conjunctival flap surgery can be an effective surgical management for this complication, returning blood supply to a thinned sclera.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | flap
|
피판재건술 | dict | 6 | |
| 해부 | scleral
|
scispacy | 1 | ||
| 해부 | blood
|
scispacy | 1 | ||
| 해부 | sclera
|
scispacy | 1 | ||
| 해부 | eyes
|
scispacy | 1 | ||
| 합병증 | Conjunctival flap
|
scispacy | 1 | ||
| 합병증 | scleromalacia
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] Scleral
|
scispacy | 1 | ||
| 약물 | mitomycin C
|
C0002475
mitomycin
|
scispacy | 1 | |
| 약물 | MMC
→ mitomycin C
|
C0002475
mitomycin
|
scispacy | 1 | |
| 질환 | scleromalacia
|
scispacy | 1 | ||
| 질환 | pterygium
|
C0033999
Pterygium
|
scispacy | 1 | |
| 질환 | calcification
|
C0006660
Physiologic calcification
|
scispacy | 1 | |
| 기타 | conjunctival flap
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 |
MeSH Terms
Adult; Calcinosis; Conjunctiva; Female; Follow-Up Studies; Humans; Male; Mitomycin; Ophthalmologic Surgical Procedures; Retrospective Studies; Sclera; Scleral Diseases; Surgery, Plastic; Surgical Flaps; Treatment Outcome
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- From Palliation After Angiosarcoma Resection to Totally Autologous Aesthetic Breast Reconstruction Combining Kiss Latissimus Dorsi Flap and Contralateral Breast Sharing Internal Mammary Artery Perforator Flap: A Case Report.
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- Otoplasty for prominent ear: A systematic review of surgical techniques.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Free flap reconstruction of a cast-related pressure ulcer in a pediatric patient with spinal muscular atrophy.